Wheat right for Proteome
Thursday, 03 July, 2008
Sydney's Proteome Systems [ASX: PXL] has sold an exclusive license for its DiagnostIQ test device to Bayer CropScience.
Under the agreement Bayer and Proteome will also collaborate to produce new products based on the technology.
Bayer will own the commercialisation rights for the products, but will pay PXL product developments and license fees as well on royalties on each sale.
Bayer and Proteome have already collaborated to produce WheatRite, a quality assurance test that can be completed in three minutes.
WheatRite will be launched this year, and is initially to be sold in Canada, with expansion to other markets including Australia to occur later.
Researchers genetically engineer snake antivenom
An international team of researchers has used genetic engineering to create so-called...
Common medications linked to adverse breast cancer outcomes
An international study has found concerning evidence about the impact of a range of common...
Saliva-based biosensor could improve heart failure detection
Scientists have created a biosensor that can rapidly detect the heart failure biomarker S100A7 in...
